Bicycle Therapeutics Plc logo

Bicycle Therapeutics Plc Share Price Today

(NASDAQ: BCYC)

Bicycle Therapeutics Plc share price is $7.39 & ₹631.59 as on 18 Apr 2025, 2.30 'hrs' IST

$7.39

-0.1

(-1.34%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Bicycle Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Bicycle Therapeutics Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bicycle Therapeutics Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Bicycle Therapeutics Plc share price movements

  • Today's Low: $7.29
    Today's High: $7.50

    Day's Volatility :2.74%

  • 52 Weeks Low: $6.10
    52 Weeks High: $28.67

    52 Weeks Volatility :78.72%

Bicycle Therapeutics Plc (BCYC) Returns

PeriodBicycle Therapeutics PlcSector (Health Care)Index (Russel 2000)
3 Months
-45.5%
-2.8%
0.0%
6 Months
-72.32%
-11.0%
0.0%
1 Year
-68.49%
-1.9%
0.0%
3 Years
-70.6%
-1.5%
-12.9%

Bicycle Therapeutics Plc (BCYC) Key Statistics

in dollars & INR

Previous Close
$7.49
Open
$7.45
Today's High
$7.495
Today's Low
$7.29
Market Capitalization
$511.4M
Today's Volume
$144.6K
52 Week High
$28.670102
52 Week Low
$6.1
Revenue TTM
$35.3M
EBITDA
$-202.7M
Earnings Per Share (EPS)
$-2.9
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-29.04%

How to invest in Bicycle Therapeutics Plc Stock (BCYC) from India?

It is very easy for Indian residents to invest directly in Bicycle Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bicycle Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bicycle Therapeutics Plc or BCYC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bicycle Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bicycle Therapeutics Plc shares which would translate to 0.116 fractional shares of Bicycle Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bicycle Therapeutics Plc, in just a few clicks!

Returns in Bicycle Therapeutics Plc (BCYC) for Indian investors in Rupees

The Bicycle Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bicycle Therapeutics Plc investment value today

Current value as on today

₹33,855

Returns

₹66,145

(-66.15%)

Returns from Bicycle Therapeutics Plc Stock

₹68,486 (-68.49%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Bicycle Therapeutics Plc (BCYC)

-57%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Bicycle Therapeutics Plc Stock from India on INDmoney has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bicycle Therapeutics Plc

  • Baker Bros Advisors LP

    15.73%

  • Point72 Asset Management, L.P.

    6.58%

  • FCPM III SERVICES BV

    4.99%

  • Westfield Capital Management Company, L.P.

    3.77%

  • Armistice Capital, LLC

    3.17%

  • Siren, L.L.C.

    2.66%

Analyst Recommendation on Bicycle Therapeutics Plc

Rating
Trend

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 18 Wall street analysts offering stock ratings for Bicycle Therapeutics Plc(by analysts ranked 0 to 5 stars)

Analyst Forecast on Bicycle Therapeutics Plc Stock (BCYC)

What analysts predicted

Upside of 274.83%

Target:

$27.70

Current:

$7.39

Insights on Bicycle Therapeutics Plc Stock (Ticker Symbol: BCYC)

  • Price Movement

    In the last 7 days, BCYC stock has moved up by 11.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 2.67M → 3.70M (in $), with an average increase of 27.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -26.54M → -51.85M (in $), with an average decrease of 26.6% per quarter
  • BCYC vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 144.2%
  • BCYC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 98.9%
  • Price to Sales

    ForBCYC every $1 of sales, investors are willing to pay $12.2, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

BCYC Bicycle Therapeutics Plc Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$35.3M
↑ 30.76%
Net Income
$-169.0M
↓ 6.44%
Net Profit Margin
-479.18%
↑ 190.54%

Bicycle Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Bicycle Therapeutics Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bicycle Therapeutics Plc (BCYC) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Bicycle Therapeutics Plc logo
-21.07%
-72.32%
-68.49%
-70.6%
-50.73%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Bicycle Therapeutics Plc

Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase I/II/III clinical trials for the treatment of high nectin-4 expressing tumors; BT5528 (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; and BT7480, a Bicycle tumor-targeted immune cell agonist molecule, which is in phase I/II targeting nectin-4 and agonizing CD137. In addition, it develops Novel CNS targets, which is in preclinical trial targeting CNS disease; Novel neuromuscular targets, which is in preclinical trial targeting neuromuscular disease; and programs that is in preclinical trial targeting radiopharmaceutical. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas. It has collaboration and license agreement with Bayer Consumer Care AG; Novartis Pharma AG; Ionis Pharmaceuticals, Inc.; and Genentech, Inc. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.
Organization
Bicycle Therapeutics Plc
Employees
305
CEO
Dr. Kevin Lee M.B.A., Ph.D.
Industry
Biotechnology

Management People of Bicycle Therapeutics Plc

NameTitle
Dr. Kevin Lee M.B.A., Ph.D.
CEO & Executive Director
Sir Gregory Paul Winter CBE, FMedsci, FRS, HonFRCP, HonFTSE, Ph.D.
Co-Founder & Non-Executive Director
Ms. Alethia Rene Young
Chief Financial Officer

Important FAQs about investing in BCYC Stock from India :

What is Bicycle Therapeutics Plc share price today?

Bicycle Therapeutics Plc share price today stands at $7.39, Open: $7.45 ; Previous Close: $7.49 ; High: $7.50 ; Low: $7.29 ; 52 Week High: $28.67 ; 52 Week Low: $6.10.

The stock opens at $7.45, after a previous close of $7.49. The stock reached a daily high of $7.50 and a low of $7.29, with a 52-week high of $28.67 and a 52-week low of $6.10.

Can Indians buy Bicycle Therapeutics Plc shares?

Yes, Indians can invest in the Bicycle Therapeutics Plc (BCYC) from India.

With INDmoney, you can buy Bicycle Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bicycle Therapeutics Plc at zero transaction cost.

How can I buy Bicycle Therapeutics Plc shares from India?

It is very easy to buy Bicycle Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bicycle Therapeutics Plc (BCYC) be purchased?

Yes, you can buy fractional shares of Bicycle Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Bicycle Therapeutics Plc stocks?

To start investing in Bicycle Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bicycle Therapeutics Plc Stock (BCYC)?

Today’s highest price of Bicycle Therapeutics Plc (BCYC) is $7.50.

Today’s lowest price of Bicycle Therapeutics Plc (BCYC) is $7.29.

What is today's market capitalisation of Bicycle Therapeutics Plc?

Today's market capitalisation of Bicycle Therapeutics Plc BCYC is 511.4M

What is the 52 Week High and Low Range of Bicycle Therapeutics Plc Stock (BCYC)?

  • 52 Week High

    $28.67

  • 52 Week Low

    $6.10

What are the historical returns of Bicycle Therapeutics Plc (BCYC)?

  • 1 Month Returns

    -21.07%

  • 3 Months Returns

    -72.32%

  • 1 Year Returns

    -68.49%

  • 5 Years Returns

    -50.73%

Who is the Chief Executive Officer (CEO) of Bicycle Therapeutics Plc ?

Dr. Kevin Lee M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Bicycle Therapeutics Plc.